A.et al (2024a)
Bacteriostatic Water FOR RESEARCH PURPOSES ONLY This compound is not FDA approved
Most importantly, IGF-1 LR3 is not meant for human use and can be legally obtained only for research purposes
Safety considerations To maximize benefits while minimizing risks, follow these essential safety guidelines: Regular check-ins with your healthcare provider Maintaining detailed records of reactions and progress Following proper injection site rotation Adhering to recommended dosage guidelines Stopping treatment if severe side effects occur The FDA has placed certain peptides under scrutiny, making it crucial to obtain CJC 1295 Ipamorelin from reputable sources
The programme spans multiple trials targeting distinct endpoints: On 21 May 2026 Eli Lilly reported topline results from TRIUMPH-1, the pivotal Phase 3 obesity trial and the programme's first Phase 3 efficacy readout: in 2,339 adults, mean weight loss at the 80-week primary endpoint reached 19.0% (4mg), 25.9% (9mg), and 28.3% (12mg) versus 2.2% for placebo (Eli Lilly investor release
The effect on stroke is remarkable (and was significant in the trials of both semaglutide and dulaglutide), amounting to an 18% risk reduction, also because the other class of new antidiabetic agents with cardiovascular benefits, the SGLT2-inhibitors, show no a similar effect on stroke (but do have a significant effect on heart failure) [24]